Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2006-02-23
2011-10-18
Chen, Shin-Lin (Department: 1632)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S320100, C514S001000, C514S04400A, C536S023500, C536S024100
Reexamination Certificate
active
08039261
ABSTRACT:
Isolated polynucleotide sequences exhibiting endothelial cell specific promoter activity, novel cis regulatory elements and methods of use thereof enabling treatment of diseases characterized by aberrant neovascularization or cell growth are disclosed.
REFERENCES:
patent: 4866042 (1989-09-01), Neuwelt
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5635385 (1997-06-01), Leopold et al.
patent: 5686281 (1997-11-01), Roberts
patent: 5734039 (1998-03-01), Calabretta et al.
patent: 5747340 (1998-05-01), Harats et al.
patent: 5792453 (1998-08-01), Hammond et al.
patent: 5830880 (1998-11-01), Sedlacek et al.
patent: 5882893 (1999-03-01), Goodearl
patent: 5906827 (1999-05-01), Khouri et al.
patent: 5916763 (1999-06-01), Williams et al.
patent: 6027743 (2000-02-01), Khouri et al.
patent: 6110480 (2000-08-01), Chu et al.
patent: 6180355 (2001-01-01), Alexander et al.
patent: 6183737 (2001-02-01), Zaleske et al.
patent: 6200751 (2001-03-01), Gu et al.
patent: 6206917 (2001-03-01), Williams et al.
patent: 6239151 (2001-05-01), Broadhurst et al.
patent: 6265216 (2001-07-01), Bennett et al.
patent: 6300127 (2001-10-01), Hair et al.
patent: 6300490 (2001-10-01), Huber et al.
patent: 6348209 (2002-02-01), Placke et al.
patent: 6376244 (2002-04-01), Atala
patent: 6403944 (2002-06-01), MacKenzie et al.
patent: 6438802 (2002-08-01), Beeman et al.
patent: 6444803 (2002-09-01), Hair et al.
patent: 6479064 (2002-11-01), Atala
patent: 6497725 (2002-12-01), Williams et al.
patent: 6503886 (2003-01-01), Baird et al.
patent: 6521750 (2003-02-01), Hair et al.
patent: 6545048 (2003-04-01), Patterson et al.
patent: 6576265 (2003-06-01), Spievack
patent: 6579697 (2003-06-01), Wallach et al.
patent: 6627189 (2003-09-01), Roth et al.
patent: 6652583 (2003-11-01), Hopkins et al.
patent: 6783776 (2004-08-01), Spievack
patent: 6866864 (2005-03-01), Mousa
patent: 7067649 (2006-06-01), Harats
patent: 7585666 (2009-09-01), Harats et al.
patent: 7625558 (2009-12-01), Greene et al.
patent: 2003/0124100 (2003-07-01), Harats
patent: 2003/0167002 (2003-09-01), Nagar et al.
patent: 2004/0048280 (2004-03-01), Harats
patent: 2004/0197860 (2004-10-01), Harats et al.
patent: 2004/0224389 (2004-11-01), Bellgrau et al.
patent: 2005/0112110 (2005-05-01), Harats
patent: 2005/0186179 (2005-08-01), Harats et al.
patent: 2006/0204478 (2006-09-01), Harats et al.
patent: 2007/0286845 (2007-12-01), Harats et al.
patent: 2008/0305088 (2008-12-01), Harats et al.
patent: 2009/0326052 (2009-12-01), Harats et al.
patent: 2010/0282634 (2010-11-01), Harats et al.
patent: 1313396 (2003-05-01), None
patent: WO 98/00013 (1998-01-01), None
patent: WO 98/37901 (1998-09-01), None
patent: WO 00/06759 (2000-02-01), None
patent: WO 02/15776 (2002-02-01), None
patent: WO 02/40629 (2002-05-01), None
patent: WO 03/033514 (2003-04-01), None
patent: WO 03/093409 (2003-11-01), None
patent: WO 2004/113497 (2004-12-01), None
patent: WO 2006/051545 (2006-05-01), None
patent: WO 2007/096882 (2007-08-01), None
patent: WO 2008/132729 (2008-11-01), None
Deonarain, 1998, Expert Opin. Ther. Pat., vol. 8, pp. 53-69.
Verma et al., Sep. 1997, Nature, vol. 389, pp. 239-242.
Eck et al., 1996, Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, p. 77-101.
Gorecki, 2001, Expert Opin. Emerging Drugs, 6(2): 187-198.
Thomas et al., 2003, Nature Reviews/ Genetics, vol. 4, p. 346-358.
Kaye et al., 1990, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6922-6926.
Davis, C. G., 1990, The New Biologist, vol. 2, No. 5, p. 410-419.
Skolnick et al., 2000, Trends in Biotech, vol. 18, p. 34-39.
Varda-Bloom et al., 2001, Gene Therapy, vol. 8, p. 819-827.
Boldin et al., 1995, The Journal of Biological Chemistry, vol. 270, No. 14, pp. 7795-7798.
Kaplan et al., 1999, Nature Medicine, vol. 5, No. 3, p. 292-297.
Percy et al., 1997, Biochemical and Molecular Medicine, vol. 62, p. 132-134.
Communication Pursuant to Article 94(3) EPC Dated May 29, 2008 From the European Patent Office Re.: Application No. 05806361.1 Mailed by Associate on Jun. 16, 2008.
Communication Pursuant to Article 96(2) EPC Dated Apr. 17, 2007 From the European Patent Office Re.: Application No. EP 02801473.6.
Examination Report Dated Sep. 5, 2005 from the Intellectual Property Office of New Zealand Re.: Application 536578 Mailed by Associate Oct. 12, 2005.
Examiner's Report Dated Dec. 10, 2008 From the Australian Government, IP Australia Re.: Application No. 2003222427.
International Preliminary Examination Report Dated May 26, 2005 From the International Preliminary Examining Authority Re.: Application No. PCT/IL03/00347.
Official Action Dated Nov. 14, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/490,746.
Official Action Dated May 28, 2008 From the Japanese Patent Office Re.: Application No. 202-543626 Mailed by Associate Jun. 9, 2008.
Requisition by the Examiner Dated Dec. 16, 2008 From the Canadian Intellectual Property Re.: 2,429,342.
Communication Pursuant to Article 94(3) EPC Dated Feb. 10, 2009 From the European Patent Office Re.: Application No. 02801473.6.
Communication Pursuant to Article 94(3) EPC Dated Feb. 16, 2009 From the European Patent Office Re.: Application No. 05806361.1.
Translation of Notice of the Reason for Rejection Dated Jan. 7, 2009 From the Korean Intellectual Property Office Re.: Application No. 2008-7018598.
Communication Pursuant to Article 94(3) EPC Dated Apr. 27, 2007 From the European Patent Office Re.: Application No. 01996590.4.
Communication Pursuant to Article 96(2) EPC Dated Dec. 21, 2006 From the European Patent Office Re.: Application No. 01996590.4.
Examination Report Dated Apr. 3, 2009 From the Intellectual Property Office of New Zealand Re.: Application No. 555612.
International Preliminary Examination Report Dated Jan. 5, 2005 From the International Preliminary Examining Authority Re.: Application No. PCT/IL02/00339.
International Preliminary Report on Patentability Dated Jan. 22, 2009 From the International Bureau of WIPO Re.: Application No. PCT/IL2007/000242.
International Preliminary Report on Patentability Dated May 24, 2007 From the International Bureau of WIPO Re.: Application No. PCT/IL2005/001195.
International Search Report Dated Apr. 29, 2009 From the International Searching Authority Re.: Application No. PCT/IL08/00543.
Invitation to Pay Additional Fees Dated Jun. 1, 2006 From the International Searching Authority Re.: Application No. PCT/IL05/01195.
Notice of Allowance Dated Aug. 14, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/075,619.
Office Action Dated Jan. 10, 2008 From the Israeli Patent Office Re.: Application No. 155940.
Office Action Dated Sep. 20, 2007, From the Israeli Patent Office Re.: Application No. 155940.
Official Action Dated Jan. 4, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/988,487.
Official Action Dated Jun. 4, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/975,619.
Official Action Dated Apr. 9, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/940,746.
Official Action Dated Jul. 10, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/490,746.
Official Action Dated Dec. 29, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/490,746.
Supplementary European Search Report Dated Mar. 21, 2006 From the European Patent Office Re.: Application No. 02801473.6.
Written Opinion Dated Apr. 29, 2009 From the International Searching Authority Re.: Application No. PCT/IL08/00543.
Bu et al., “Identification of An Endothelial Cell-Specific Regulatory Region in the Murine Endothelin-1 Gene”, The Journal of Biological Chemistry, 272(51): 32613-32622, 1997.
Notice of Allowance Dated Jun. 11, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/490,746.
Search Report and Written Opinion Dated Apr. 21, 2009 From the Intellectual Property Office of Singapore Issued by the Austrian Patent Office Re.: Application No. 200703466-3.
Aird et al. “Human von Willebrand Factor Gene Sequences Target Expression to A Subpopulation of Endothelial Cells in Transgeni
Bangio Livnat
Breitbart Eyal
Greenberger Shoshana
Harats Dror
Peled Michael
Chen Shin-Lin
Vascular Biogenics Ltd.
LandOfFree
Promoters exhibiting endothelial cell specificity and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Promoters exhibiting endothelial cell specificity and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promoters exhibiting endothelial cell specificity and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4253120